These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 689796)

  • 1. Individualization of drug dosage during long-term treatment with phenprocoumon (Falithrom).
    Haustein KO; Richter M; Vogel G; Mittag E
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):372-6. PubMed ID: 689796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between phenprocoumon and phytomenadion: a pharmacokinetic investigation in healthy volunteers.
    Haustein KO
    Biomed Biochim Acta; 1984; 43(12):1417-24. PubMed ID: 6534380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacokinetic model of the adjustment of phenprocoumon (Falithrom) dosage.
    Barthel W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):838-50. PubMed ID: 6083961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjustment of phenprocoumon dosage utilizing a pharmacokinetic model.
    Böhm K; Vogel G; Barthel W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):141-6. PubMed ID: 2459009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of phenprocoumon.
    Haustein KO; Hüller G
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):192-7. PubMed ID: 8032579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic properties of oral anticoagulants, especially phenprocoumon.
    Haustein KO
    Semin Thromb Hemost; 1999; 25(1):5-11. PubMed ID: 10327214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Observations in phenprocoumon (Marcumar) poisoning. Elimination and serum binding of the anticoagulant atatoxic blood concentration].
    Held H; von Busse G; Meissner J
    Dtsch Med Wochenschr; 1980 Jun; 105(24):860-3. PubMed ID: 7418621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of daily administration of naproxen on the prothrombin complex activity in patients under long-term therapy with phenprocoumon.
    Petersen PB; Husted S; Mortensen A; Andreasen F
    Scand J Rheumatol; 1979; 8(1):54-6. PubMed ID: 311940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interaction of rifampicin with phenprocoumon (author's transl)].
    Held H
    Dtsch Med Wochenschr; 1979 Sep; 104(37):1311-4. PubMed ID: 477551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors responsible for interindividual differences in the dose requirement of phenprocoumon.
    Trenk D; Althen H; Jähnchen E; Meinertz T; Oie S
    Eur J Clin Pharmacol; 1987; 33(1):49-54. PubMed ID: 3691595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Probenecid affects liver metabolism].
    Bammel A; Mönig H; Zurborn KH; Ohnhaus EE; Kirch W
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1831-4. PubMed ID: 2609138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of oral anticoagulation by an amidolytic factor X assay. A long-term study in 42 patients.
    Lämmle B; Bounameaux H; Marbet GA; Eichlisberger R; Duckert F
    Thromb Haemost; 1980 Dec; 44(3):150-3. PubMed ID: 7008244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the interactions of chlordiazepoxide, nitrazepam, and diazepam with phenprocoumon (author's transl)].
    Kinawi A; Baumgartl I
    Arzneimittelforschung; 1976; 26(11):2019-23. PubMed ID: 1037237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of flupirtine coadministration on phenprocoumon plasma concentrations and prothrombin time.
    Harder S; Thürmann P; Hermann R; Weller S; Mayer M
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):577-81. PubMed ID: 7874369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coumarin therapy during antirheumatism therapy with sulindac].
    Schenk H; Klein G; Haralambus I; Goebel R
    Z Rheumatol; 1980; 39(3-4):102-8. PubMed ID: 6968485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Change from heparin to phenprocoumon].
    Heene DL
    Dtsch Med Wochenschr; 1978 Sep; 103(36):1394. PubMed ID: 679853
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies of the interractions of cyclamate with phenprocomon (author's transl)].
    Kinawi A; Baumgartl I
    J Clin Chem Clin Biochem; 1977 Jun; 15(6):345-8. PubMed ID: 894206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon.
    O'Reilly RA
    Arch Intern Med; 1982 Sep; 142(9):1634-7. PubMed ID: 7114982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma hypercoagulability after termination of oral anticoagulants.
    Harenberg J; Haas R; Zimmermann R
    Thromb Res; 1983 Mar; 29(6):627-33. PubMed ID: 6857601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment basis for anticoagulants in horses].
    Sinn D; Wintzer HJ
    Tierarztl Prax; 1990 Oct; 18(5):507-11. PubMed ID: 2264055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.